Novel membrane-based PFO Sealing system designed to address limitations of current stroke prevention devices NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Recross Cardio Inc., a structural heart company ...
Please provide your email address to receive an email when new articles are posted on . Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ...
A new study in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier, ...
Having a residual shunt after percutaneous patent foramen ovale (PFO) closure was associated with an elevated risk of stroke or transient ischemic attack (TIA) recurrence years after the procedure, ...
The first-ever guidelines for interventional cardiologists using percutaneous patent foramen ovale closure recommend expanding the use of the procedure beyond the Food and Drug Administration-approved ...
NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Recross Cardio Inc., a structural heart company pioneering next-generation membrane sealing technology, today announces the first clinical implantation with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback